We are submitting herewith the Certificate issued by Venture Capital and Corporate Investments Private Limited in compliance with Regulation 74(5) of the SEBI (D&P) Regulations, 2018 for ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Hindustan Bio Sciences Ltd has submitted a compliance certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended June 30, 2025. The certificate, issued by its Registrar and Share Transfer Agent (RTA) — Venture Capital and Corporate Investments Pvt. Ltd. — confirms that no equity share certificates were received for dematerialization during the period from April 1, 2025 to June 30, 2025. The filing was signed by Managing Director Venkata Mohan Raju Jampani (DIN: 00060800) and submitted to BSE on July 15, 2025. This is a standard quarterly compliance requirement and does not involve any capital action, share movement, or corporate decision.
This is a routine procedural filing with no material impact on the company's financials, operations, or stock price. Shareholders do not need to take any action — it merely confirms routine regulatory compliance for Q1 FY26.